摘要 |
This invention is directed to compounds of formula (I): where r, q, R, R2, R3, R4a, R4b, R4c, R5a, R5b, R5c, R6a, R6b, R6c, R7, R8, R9 and R10 are described herein, or pharmaceutically acceptable salts, solvates, polymorphs, ammonium ions, N-oxides or prodrugs thereof; which are leukotriene A4 hydrolase inhibitors and which are therefore useful in treating inflammatory disorders. Pharmaceutical compositions comprising the compounds of the invention and methods of using and preparing the compounds of the invention are also disclosed. |
申请人 |
BAYER SCHERING PHARMA AKTIENGESELLSCHAFT;CHEN, MING;CLARET, EMMANUEL;CLEVE, ARWED;DAVEY, DAVID;GUILFORD, WILLIAM;KHIM, SEOCK-KYU;KIRKLAND, THOMAS;KOCHANNY, MONICA;LIANG, AMY;LIGHT, DAVID;PARKINSON, JOHN;VOGEL, DAVID;WEI, GUO, PING;YE, BIN;YE, HONG |
发明人 |
CHEN, MING;CLARET, EMMANUEL;CLEVE, ARWED;DAVEY, DAVID;GUILFORD, WILLIAM;KHIM, SEOCK-KYU;KIRKLAND, THOMAS;KOCHANNY, MONICA;LIANG, AMY;LIGHT, DAVID;PARKINSON, JOHN;VOGEL, DAVID;WEI, GUO, PING;YE, BIN;YE, HONG |